Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis

<div>Construction of a prognostic nomogram prediction model for LUAD. Prognostic nomogram prediction model for LUAD based on L1CAM, ETS1, FOSL2, and STAT1 (a). ROC curves of L1CAM, ETS1, FOSL2, and STAT1 associated with LUAD (b). Calibration curves for this nomogram to predict the probability of survival at 1, 2, and 3 years for LUAD patients (c). “Observed fraction survival probability” means the actual observed survival rate. “Nomogram predicted survival probability” refers to the survival rate that was predicted.</div>

Disease Markers

fig4

Figure 4

Figure 4: Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis 

Figure 4 | Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis 